UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity

Journal of medicinal chemistry, 2010-12, Vol.53 (24), p.8546-8555

2010

Volltextzugriff (PDF)

Drugging the HDAC6–HSP90 interplay in malignant cells

Trends in pharmacological sciences (Regular ed.), 2014-10, Vol.35 (10), p.501-509

2014

Volltextzugriff (PDF)

Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases

MedChemComm, 2012-07, Vol.3 (7), p.829

2012

Volltextzugriff (PDF)

Generation and Assessment of Fusions Between HDACi and TKi

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1510, p.405

2017

Volltextzugriff (PDF)

Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[ b]furan-2-yl)methanones

Bioorganic & medicinal chemistry, 2007-03, Vol.15 (5), p.2187-2197

2007

Volltextzugriff (PDF)

Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors

European journal of medicinal chemistry, 2018-05, Vol.152, p.329-357

2018

Volltextzugriff (PDF)

Biological and structural investigation of tetrahydro-β-carboline-based selective HDAC6 inhibitors with improved stability

European journal of medicinal chemistry, 2024-10, Vol.276, p.116676, Article 116676

2024

Volltextzugriff (PDF)

Enantioselective synthesis and biological investigation of tetrahydro‐β‐carboline‐based HDAC6 inhibitors with improved solubility

Archiv der Pharmazie (Weinheim), 2019-06, Vol.352 (6), p.e1900026-n/a

2019

Volltextzugriff (PDF)

Potential Antipsoriatic Agents: Lapacho Compounds as Potent Inhibitors of HaCaT Cell Growth

Journal of natural products (Washington, D.C.), 1999-08, Vol.62 (8), p.1134-1136

1999

Volltextzugriff (PDF)

Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors

Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3454-3477

2018

Volltextzugriff (PDF)

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells

Cell chemical biology, 2022-03, Vol.29 (3), p.398-411.e4

2022

Volltextzugriff (PDF)

HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3

Cellular signalling, 2017-11, Vol.39, p.9-17

2017

Volltextzugriff (PDF)

Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells

Cellular signalling, 2017-01, Vol.29, p.218-225

2017

Volltextzugriff (PDF)

A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer

Bioorganic chemistry, 2022-02, Vol.119, p.105505, Article 105505

2022

Volltextzugriff (PDF)

Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3

Archives of toxicology, 2022-01, Vol.96 (1), p.177-193

2022

Volltextzugriff (PDF)

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia

European journal of medicinal chemistry, 2020-05, Vol.193, p.112232, Article 112232

2020

Volltextzugriff (PDF)

Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases

Journal of medicinal chemistry, 2009-04, Vol.52 (8), p.2265-2279

2009

Volltextzugriff (PDF)

Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells

Archives of toxicology, 2017-05, Vol.91 (5), p.2191-2208

2017

Volltextzugriff (PDF)

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1

Cancers, 2019-09, Vol.11 (10), p.1436

2019

Volltextzugriff (PDF)

Corrigendum to “A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer” [Bioorgan. Chem. 119 (2022) 105505]

Bioorganic chemistry, 2024-05, Vol.146, p.107248-107248, Article 107248

2024

Volltextzugriff (PDF)

3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances

European journal of medicinal chemistry, 2006-02, Vol.41 (2), p.176-191

2006

Volltextzugriff (PDF)

Human platelet lysate as validated replacement for animal serum to assess chemosensitivity

ALTEX, alternatives to animal experimentation, 2019-01, Vol.36 (2), p.277-288

2019

Volltextzugriff (PDF)

2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors

Journal of medicinal chemistry, 2007-09, Vol.50 (18), p.4405-4418

2007

Volltextzugriff (PDF)

2-Arylamino-4-Amino-5-Aroylthiazoles. “One-Pot” Synthesis and Biological Evaluation of a New Class of Inhibitors of Tubulin Polymerization

Journal of medicinal chemistry, 2009-09, Vol.52 (17), p.5551-5555

2009

Volltextzugriff (PDF)

Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones

Bioorganic & medicinal chemistry, 2012-01, Vol.20 (1), p.125-136

2012

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity

Drugging the HDAC6–HSP90 interplay in malignant cells

Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases

Generation and Assessment of Fusions Between HDACi and TKi

Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[ b]furan-2-yl)methanones

Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors

Biological and structural investigation of tetrahydro-β-carboline-based selective HDAC6 inhibitors with improved stability

Enantioselective synthesis and biological investigation of tetrahydro‐β‐carboline‐based HDAC6 inhibitors with improved solubility

Potential Antipsoriatic Agents: Lapacho Compounds as Potent Inhibitors of HaCaT Cell Growth

Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells

HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3

Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells

A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer

Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia

Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases

Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1

Corrigendum to “A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer” [Bioorgan. Chem. 119 (2022) 105505]

3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances

Human platelet lysate as validated replacement for animal serum to assess chemosensitivity

2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors

2-Arylamino-4-Amino-5-Aroylthiazoles. “One-Pot” Synthesis and Biological Evaluation of a New Class of Inhibitors of Tubulin Polymerization

Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones

Suchergebnisse filtern